NCT01523119View on ClinicalTrials.gov

Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

October 31, 2006

Conditions
Healthy
Interventions
DRUG

Ondansetron

Orally Disintegrating Tablets 8 mg

Trial Locations (1)

Unknown

Clinical Pharmacology Unit, Majeedia Hospital (2nd Floor), New Delhi

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT01523119 - Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed Conditions | Biotech Hunter | Biotech Hunter